✦ LIBER ✦

Subcutaneous recombinant interleukin-2 plus chemotherapy with cisplatin and dacarbazine in metastatic melanoma

✍ Scribed by M. Guida; A. Latorre; A. Mastria; M. De Lena

Book ID: 116166718
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 395 KB
Volume: 32
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)00662-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ambulatory treatment of metastatic melan

Ambulatory treatment of metastatic melanoma associating subcutaneous dacarbazine, interferon α and interleukin-2

✍ B. Dréno; D. Cupissol; P. Joly; B. Sassolas; T. Bonneterre; J.M. Tourani 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 451 KB

The combination of recombinant interleuk

The combination of recombinant interleukin-2 and dacarbazine (DTIC) in metastatic malignant melanoma

✍ Flaherty, L. 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Chemohormone therapy of metastatic melan

Chemohormone therapy of metastatic melanoma with megestrol acetate plus dacarbazine, carmustine, and cisplatin

✍ Larry Nathanson; M. Ashraf Meelu; Richard Losada 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 3 views

High-dose cisplatin plus dacarbazine in

High-dose cisplatin plus dacarbazine in the treatment of metastatic melanoma

✍ John R. Murren; William Derosa; Henry J. Durivage; Carol Davis; Robert Makuch; C 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 2 views

Phase I trial of subcutaneous recombinan

Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma

✍ Omar Eton; Michael G. Rosenblum; Sewa S. Legha; Wehei Zhang; Mary Jo East; Agop 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 3 views

## Abstract ## BACKGROUND Interleukin‐2 (IL‐2) has activity in metastatic melanoma when given in high doses by the intravenous (IV) route, but its side effects and effectiveness when given in intermediate to high doses by the subcutaneous (SC) route have not been studied adequately. This study sou

A phase II study of dacarbazine and cisp

A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic malignant melanoma

✍ Lawrence E. Flaherty; Bruce G. Redman; Silvana Martino; Michael Kraut; Manuel Va 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB